Skip to main content
Contact Us
Subscribe
E-Edition
41°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ATAI
Recent news which mentions ATAI
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
October 02, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Cannabis
ATAI
HUGE
From
Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
DRUG
MNMD
Psychedelics Financing
From
Benzinga
Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics
September 23, 2023
Tickers
ATAI
GOOGL
TSLA
Tags
Elon Musk
Lauren Mugglebee
Penny Stocks
From
Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
IXHL
Markets
SILO
From
Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
Tickers
ATAI
CYBN
DMTTF
MNMD
Tags
Psychedelics Financing
MNMD
DMTTF
From
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Tickers
ATAI
CMPS
CYBN
JAZZ
Tags
News
CMPS
Penny Stocks
From
Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
PHRRF
OPTHF
Psilocybin program
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
IWINF
Psychedelics Reform
SILFF
From
Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Global
Market News
Psychedelics
From
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
MNMD
Management
MYCOF
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
TRUFF
IXHL
Cannabis
From
Benzinga
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
August 10, 2023
Tickers
ATAI
CMPS
Tags
News
Ibogaine trial
Psychedelic/Assisted Therapies
From
Benzinga
Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
August 09, 2023
Tickers
ATAI
JNJ
Tags
Cannabis
ATAI
Ketamine Therapy for depression
From
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Benzinga
PSIL
Market News
From
Benzinga
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
July 28, 2023
Tickers
ATAI
CMPS
DMTTF
DRUG
Tags
SILO
Markets
DMT Entities
From
Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers
ATAI
CMPS
HTGC
Tags
Global
Psychedelics
Market News
From
Benzinga
TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
June 21, 2023
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
ATAI
CYBN
MNMD
From
MarketWatch
MAPS' Psychedelic Science 2023: Gov. Polis To Open Event, New Shulgin Compounds To Be Revealed
June 14, 2023
Tickers
ATAI
Tags
News
Multidisciplinary Association for Psychedelic Studies
Penny Stocks
From
Benzinga
3 Penny Stocks to Make You the Millionaire Next Door
May 25, 2023
Tickers
ATAI
RIGL
SRNEQ
Tags
SRNEQ
RIGL
Market News
From
InvestorPlace
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
Tickers
ATAI
CMND
CMPS
CYBN
Tags
OPTHF
Psychedelics Financing
NUGL
From
Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
May 11, 2023
Tickers
ATAI
CMPS
Tags
CMPS
Psychedelic/Assisted Therapies
DMT Clinical Trial
From
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
April 21, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Markets
SEEL
ATAI
From
Benzinga
Invitae, CSX And Other Big Stocks Moving Higher In Friday's Pre-Market Session
April 21, 2023
Tickers
AMTD
ATAI
CSX
ITUB
Tags
ATAI
Small Cap
WISH
From
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
April 20, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Cannabis
ATAI
SEEL
From
Benzinga
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?
April 20, 2023
Tickers
ATAI
CMPS
Tags
CMPS
Recent Press Releases
Market News
From
Motley Fool
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
April 19, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
GHRS
CMPS
Movers
From
Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2023
April 18, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
MNMD
Movers
CMPS
From
Benzinga
Psychedelic Stock Gainers And Losers From April 17, 2023
April 17, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Movers
MNMD
GHRS
From
Benzinga
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
April 17, 2023
Tickers
ATAI
AWKNF
CYBN
FLHLF
Tags
Psychedelic/Assisted Therapies
Legal
Earnings
From
Benzinga
Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
April 14, 2023
Tickers
ATAI
Tags
Psychedelic/Assisted Therapies
Penny Stocks
Perception Neurosciences
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.